Chinanews.com, Beijing, December 13 (Zuo Yuqing) The hair transplant company has also gone public!
On the 13th, Yonghe Medical Group Co., Ltd. (abbreviated as "Yonghe Medical", stock code 02279.HK) was listed on the main board of the Hong Kong Stock Exchange.
It is understood that Morgan Stanley and CICC are the joint sponsors of Yonghe Medical's listing.
The listing of Yonghe Medical also introduced 10 blockbuster investors, including NCCFund (NCCCapital), Qingchi Capital, HudsonBay, Eli Lilly Asia, E Fund, WTCapital, EnrealandForrealFunds, Ivy, AthosCapital and YorkAsianOpportunities.
Yonghe Medical goes on sale at the gong.
For picture
Zhang Yu, chairman of Yonghe Medical, said, “This successful listing will provide sufficient financial support for the company’s future expansion and layout, and it also means that the company has officially entered the international capital market. Yonghe will take the listing as an opportunity to grasp the industry Development trend, enhance comprehensive competitiveness, and continue to improve operation and management capabilities."
With the increase in hair transplant groups, Yonghe Medical announced that its total revenue in 2018 was 934 million yuan; in 2019 it was 1.22 billion yuan, a year-on-year increase of 31.1%; in 2020, it was 1.64 billion yuan, a year-on-year increase of 33.8%.
In the first half of 2021, its revenue was 1.05 billion yuan, a year-on-year increase of 75.1%.
(Finish)